Supine Exercise in Hepatopulmonary Syndrome Patients With Orthodeoxia
NCT04004104 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2023-05-10
Summary
Hepatopulmonary syndrome (HPS) is a rare condition that presents in about a quarter of patients with liver cirrhosis. In addition, a small subset of these HPS patients also have orthodeoxia, defined as a drop in oxygen levels when they are sitting up (upright), as opposed to lying flat (supine). At present, there is little known about this condition. Patients diagnosed with HPS and orthodeoxia experience reduced ability to exercise, especially when upright. While standard cardiopulmonary exercise is routinely performed in the sitting position, there are machines that enable candidates to exercise in the supine position. This is especially relevant in patients with severe HPS, with clinically significant orthodeoxia, where conventional upright exercise is difficult. Currently there is a gap in the literature regarding the efficacy of supine exercise compared to upright exercise in these patients. Due to their improvement in dyspnea when lying supine, it is predicted that these patients will be able to exercise for a greater length of time and have increased exercise capacity, which can be projected to improve outcomes pre- and post-transplant.
Overall, HPS patients tend to experience hypoxemia and exercise limitation. Exercise limitation impacts quality of life, incidence and severity of comorbid conditions, and in those who are liver transplant candidates, low exercise tolerance deleteriously impacts transplant outcomes. Accordingly, a strategy that enables patients to exercise more often and/or for longer periods would offer direct benefits to patients with HPS, and if employed as part of an exercise program, could also improve exercise capacity, and thus, liver transplant outcomes.
The purpose of this study is to investigate the effect of supine, compared to upright position on exercise in patients with HPS and orthodeoxia. We hypothesize that these patients will be able to exercise for longer in the supine compared to the upright position, given improved oxygen levels when supine.
Conditions
- Hepatopulmonary Syndrome
Interventions
- DIAGNOSTIC_TEST
-
Upright Exercise
Exercise is generally performed in the upright position.
- DIAGNOSTIC_TEST
-
Supine Exercise
Since HPS patients with orthodeoxia experience an improvement in their symptoms and oxygen levels when supine, the intervention will involve them performing exercise in the supine position.
Sponsors & Collaborators
-
Unity Health Toronto
lead OTHER
Principal Investigators
-
Samir Gupta, MD, MSc · Clinician-Scientist
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-07-24
- Primary Completion
- 2023-12-01
- Completion
- 2024-08-31
Countries
- Canada
Study Locations
More Related Trials
-
Feasibility of an App-based Nutrition & Exercise Program in Cirrhosis
NCT05033327 ·Status: COMPLETED ·Phase: NA
-
Muscle Mass Via UltraSound in Cirrhosis (MMUSCLE)
NCT06345547 ·Status: RECRUITING
-
Effect of Transjugular Intrahepatic Portosystemic Shunt on Oxygenation in Cirrhotic Patients With Hepatopulmonary Syndrome
NCT02148536 ·Status: COMPLETED
-
Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis
NCT00570622 ·Status: COMPLETED ·Phase: PHASE4
-
Frailty in Patients With Cirrhosis: Prognostic Value of the Phase Angle in Hospitalized Patients and Effect of Multifactorial Intervention
NCT04243148 ·Status: COMPLETED ·Phase: NA
-
Mechanism of TIPS to Improve Sarcopenia
NCT06794853 ·Status: RECRUITING
-
Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis
NCT00332904 ·Status: UNKNOWN ·Phase: PHASE4
-
Pilot Study of Pentoxifylline for Hepatopulmonary Syndrome
NCT00593658 ·Status: TERMINATED ·Phase: PHASE1
-
Beta-Hydroxy-Beta-Methylbutyrate Supplementation and Physical Activity in Liver Cirrhosis: a Controlled Trial
NCT03892070 ·Status: UNKNOWN ·Phase: NA
-
Mechanisms of Malnutrition in Cirrhosis With Portosystemic Shunting
NCT03121404 ·Status: RECRUITING
-
Oxidative Stress and Microcirculation in Patient With Hepatic Failure Undergoing Liver Support Treatment
NCT00772252 ·Status: UNKNOWN
-
HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
NCT05205954 ·Status: RECRUITING ·Phase: NA
-
Study of the Benefit of Exercise and Aminoacid Supplements in Cirrhotic Patients
NCT01060813 ·Status: COMPLETED ·Phase: NA
-
Comparing Outcome of Thoracocentesis and Pigtail Catheter Drainage in Treatment of Patients With Hepatic Hydrothorax
NCT06319547 ·Status: RECRUITING ·Phase: NA
-
PiCCO Guided Therapy in Liver Cirrhosis
NCT00232427 ·Status: COMPLETED ·Phase: NA
-
PEriToneal Catheter Versus Repeated Paracentesis for Ascites in Cirrhosis
NCT03027635 ·Status: TERMINATED ·Phase: NA
-
Intraabdominal Hypertension and Occurrence of Microaspiration in Cirrhotics Under Mechanical Ventilation
NCT04530760 ·Status: RECRUITING
-
Characterization of the Nutritional Status in the Patient With Liver Cirrhosis
NCT04073693 ·Status: COMPLETED ·Phase: NA
-
Effect of Branched-chain Amino Acid Supplementation and Exercise on Muscle Quantity and Quality in Cirrhosis
NCT06088550 ·Status: COMPLETED ·Phase: NA
-
Transitional Care Program for Fluid Overload in Cirrhosis
NCT06174272 ·Status: RECRUITING ·Phase: NA
-
Treatment of Sarcopenia Improves the Muscle Mass and Muscle Strength of Patients With Liver Cirrhosis-Child C
NCT03633279 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The Effect of a Large-volume Paracentesis on Fatigue, Sleep, and Quality of Life in Cirrhosis
NCT01777971 ·Status: WITHDRAWN
-
Phase Angle and Mortality in Patients With Cirrhosis
NCT02023177 ·Status: COMPLETED
-
Daily Step Count Using Pedometer for Sarcopenic Management in Patient With Cirrhosis: Randomized Controlled Trial
NCT06231420 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Efficacy and Safety of Plasma Exchange Compared to Standard Medical Therapy in Patients With Severe Drug Induced Liver Injury With or Without Underlying Chronic Liver Disease.
NCT04015570 ·Status: UNKNOWN ·Phase: NA